Nisa Investment Advisors’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8
Closed -$5K 2808
2023
Q1
$5K Sell
8
-15
-65% -$13.3K ﹤0.01% 2237
2022
Q4
$20K Buy
23
+4
+21% +$5.03K ﹤0.01% 2055
2022
Q3
$27K Buy
19
+11
+138% +$14.5K ﹤0.01% 1960
2022
Q2
$6K Sell
8
-336
-98% -$346K ﹤0.01% 2249
2022
Q1
$532K Buy
344
+337
+4,814% +$455K ﹤0.01% 1060
2021
Q4
$9K Hold
7
﹤0.01% 2036
2021
Q3
$23 Hold
7
﹤0.01% 2056
2021
Q2
$31 Buy
+7
New +$27.6K ﹤0.01% 2041

Other funds holding BNGO

Nisa Investment Advisors's BNGO Position: Q2 2023 in Review

Nisa Investment Advisors sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 8 shares — an estimated $5K sold.

Nisa Investment Advisors first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $532K in Q1 2022. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Nisa Investment Advisors reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 8 Bionano Genomics shares in Q2 2023, an estimated $5K.
  • Nisa Investment Advisors first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Nisa Investment Advisors's Bionano Genomics position peaked at $532K in Q1 2022.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Nisa Investment Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.